Triple your efficiency: one overhead stirrer & 3 x temperature-controlled screening reactions

As the biotech in­dus­try grap­ples with how to fund drug de­vel­op­ment in a world of in­creas­ing re­search costs, ris­ing drug prices and gov­ern­ment-re­lat­ed risk, a

Pro­QR has inked a deal with French com­pa­ny Lab­o­ra­toires Théa and trans­fer­ring two late-stage can­di­dates to the com­pa­ny in a deal worth up to €147.5